Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model
Related Posts
Holland AE, Krishnan JA, Lacasse Y, Gomes H, Björklund F, Casaburi R, de Andrade J, Eakin MN, Hui D, Jacobs SS, Kawachi S, Khor YH,[...]
Mora R, Irannejad K, Abbas N, Mogga P, Iskander B, Hubbard L, Roy S, Lakshmanan S, Budoff M, Krishnan S. Emerging quantitative CCTA imaging biomarkers[...]
Arai D, White Q, Ichikawa K, McClelland RL, Johnson WC, Yabuki M, Hansen S, Budoff MJ. Association between depressive symptoms and thoracic aortic calcification, and[...]